Advertisement
Australia markets closed

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • AUD/USD

    0.6540
    +0.0017 (+0.26%)
     

  • OIL

    84.34
    +0.77 (+0.92%)
     

  • GOLD

    2,361.00
    +18.50 (+0.79%)
     

  • Bitcoin AUD

    97,519.12
    +1,534.99 (+1.60%)
     

  • CMC Crypto 200

    1,385.44
    -11.09 (-0.79%)
     

  • AUD/EUR

    0.6103
    +0.0030 (+0.49%)
     

  • AUD/NZD

    1.0988
    +0.0030 (+0.28%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,117.00
    +38.14 (+0.47%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    18,076.32
    +159.04 (+0.89%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Should You Follow Cathie Wood Into This Coronavirus Stock?

Adria Cimino, The Motley Fool
·5-min read
Should You Follow Cathie Wood Into This Coronavirus Stock?

Cathie Wood, founder, CEO, and chief investment officer (CIO) of ARK Invest. Earlier this month, the ARK Genomic Revolution fund purchased more than 100,000 shares of Regeneron Pharmaceuticals (NASDAQ: REGN). Regeneron, maker of an antibody cocktail to treat COVID-19, is the fund's fourth-biggest holding.

Continue reading